Chronic myeloid leukemia
Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of the primitive hemopoietic stem cell. The disease is monoclonal in origin, affecting myeloid, monocytic, erythroid, megakaryocytic, B-cell, and, sometimes, T-cell lineages.
CML accounts for 15% of all leukemias in adults. In adults the incidence is approximately 1 to 1.5 cases per 100,000 population.
Estimated new cases and deaths from chronic myeloid leukemia in the United States in 2005:
- New cases: 4,600
- Deaths: 850
The male-to-female ratio is 1.4 to 2.2:1.
The median age of patients with Ph1-positive CML (Chronic Myeloid Leukemia) is 67 years of age.
Race and ethnicity
Incidence rates are similar among all race/ethnicities.
CML has been observed in studies following the atom bomb explosions in Japan in 1945.
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community
Editorial activities: Publish, peer review, edit online articles.
Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.